Bryan Stuart

Bryan E.
Stuart currently works at Atavistik Bio, Inc., as Chief Executive Officer & Director from 2023.
Mr. Stuart also formerly worked at Kastle Therapeutics LLC, as President & Chief Executive Officer in 2017, Fulcrum Therapeutics, Inc., as President, Chief Executive Officer & Director from 2022 to 2023, Yarra Therapeutics LLC, as President & Chief Executive Officer from 2017 to 2018, EKR Therapeutics, Inc., as Chief Corporate Development Officer from 2011 to 2012, OVATION Pharmaceuticals, Inc., as VP-Corporate Development, Merger & Acquisitions from 2001 to 2010, and Civitas Therapeutics, Inc., as Chief Business Officer from 2012 to 2014.
Mr. Stuart received his undergraduate degree from the University of Illinois and Masters Business Admin degree from Kellogg School of Management.